United States · FDA National Drug Code directory
Revlimid
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59572-405_9329fd28-b848-4013-92e0-a68270328336
- Product NDC
- 59572-405
- Form
- CAPSULE
- Composition / generic term
- Lenalidomide
- Labeler
- Celgene Corporation
- Marketing category
- NDA
- Marketing start / end (source format)
- 20051227
- Source listing expiry
- 20271231
Source-listed ingredients
- LENALIDOMIDE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (59572-405-00) · 59572-405-00
- 28 CAPSULE in 1 BOTTLE (59572-405-28) · 59572-405-28
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →